Abstract. Axonal transport plays a crucial role in neuronal morphogenesis, survival, and function. Despite its importance, however, the molecular mechanisms of axonal transport remain mostly unknown because a simple and quantitative assay system for axonal transport has been lacking. In order to better characterize the molecular mechanisms involved in axonal transport, we here developed a computer-assisted monitoring system. Using lipophilic fluorochrome chloromethylbenzamido dialkylcarbocyanine (CM-DiI) as a labeling dye, we have successfully labeled membranous organelles in cultured chick dorsal root ganglia neurons. We confirmed that sodium azide, an ATPase inhibitor, and nocodazole, a microtubule-destabilizing agent, markedly suppressed anterograde and retrograde axonal transport of CM-DiI-labeled particles. We further tested the effects of several anti-neoplastic drugs on axonal transport. Paclitaxel, vincristine, cisplatin, and oxaliplatin, all of which are known to be neurotoxic and to cause neurological symptoms, suppressed anterograde and retrograde axonal transport. Another series of anti-neoplastic drugs, including methotrexate and 5-fluorouracil, did not affect the axonal transport. This is the first report of an automated monitoring system for axonal transport. This system will be useful for toxicity assays, characterizing axonal transport, or screening drugs that may modify neuronal functions.
Introduction
Neurons are highly polarized cells each consisting of a cell body, axon, and dendrites; and proper neuronal differentiation, survival, and function are heavily dependent on the axonal and dendritic transport machinery. In axons, the molecules required for synapse formation are synthesized in the cell body and transported to the synaptic area. Molecules such as neurotrophins are received in the growth cone and transported to the cell body. This transport machinery is dependent on two families of motor proteins to transport molecules along microtubules, kinesin and dynein. Defects in axonal transport reportedly can lead to neurodegenerative pathology and related disorders such as Schizophrenia, Alzheimer's disease, Parkinson's disease, and other motor neuron diseases (1, 2) . Certain pharmaceutical agents such as anti-tumor drugs have been reported to induce suppression of axonal transport in peripheral sensory neurons and are associated with neuropathy (3). However, the mechanisms and pathophysiological significance of axonal transport at present are far from understood.
Conventional assay systems, such as the isotope tracer technique, video-enhanced differential interference contrast (DIC) microscopy, or fluorescence recovery after photobleaching (FRAP) via the introduction of green fluorescence protein (GFP)-tagged proteins, have been utilized for the analysis of axonal transport (4) . We pre-viously reported using a video-enhanced contrast differential interference video camera system that a repulsive axon guidance molecule, Semaphorin3A, induced anterograde and retrograde axonal transport (5 -7). However, such methodologies are time-consuming and depend upon a subjective element. Therefore, the development of an automated and objective assay system to evaluate axonal transport has long been awaited. Here, we first used chloromethylbenzamide dialkylcarbocyanine (CMDiI) (8, 9) as a probe to visualize membranous organelles being transported along the axon in chick dorsal root ganglion (DRG) neurons. We recorded the moving CMDiI-labeled particles with a laser-scanning microscope, analyzed the axonal transport rate, and examined the effects of several pharmaceutical agents on axonal transport. In our method, the differential interference and fluorescence microscopic sequential images are used as inputs. The software consists of two phases, the detection of a particle and then the tracking of a particle. In the particle detection phase, an axonal region is first detected on a differential interference microscopy image. The particles are then detected using a separability filter and the axonal region on a fluorescence microscopic image. In the particle-tracking phase, after particle correspondence detection between successive image frames is performed, the tracked routes are globally evaluated based on a particle movement diagram model to find any failures in the tracked routes. This configuration enables the precise routes of vesicle movements to be stably obtained. A preliminary report has been presented elsewhere (10) .
Materials and Methods

Materials
CM-DiI was purchased from Invitrogen (Eugene, OR, USA). Poly-L-lysine, sodium azide, nocodazole, vinblastine sulfate, cisplatin, oxaliplatin, 5-fluorouracil, cytochalasin B, and lidocaine were from Sigma (St. Louis, MO, USA). Paclitaxel was from Wako (Osaka). Methotrexate was from Fluka (Buchs, Switzerland). mitoTracker and erTracker were purchased from Molecular Probes (Eugene, OR, USA).
Chick DRG culture and CM-DiI staining
DRGs were removed from embryonic day-7 chick embryos, and they were treated with 0.25% trypsin in Ca 2+ -and Mg
2+
-free phosphate-buffered saline at 37°C for 6 min and then the reaction was stopped by adding trypsin-free medium, as described (11) . The cells were washed three times in Ham's F12 medium (Sigma) containing 10% fetal bovine serum and 2.5 S nerve growth factor (10 ng/ml, Wako), dissociated in the medium, and seeded onto a 35-mm cell culture dish (Corning, Corning, NY, USA). The cells were cultured for 1 h, the medium was collected, and replated onto a Poly-L-lysine-coated 35-mm glass base dish (AGC Technoglass, Chiba). The cells were then cultured at 37°C for 12 -14 h. The cultured cells were washed three times in Leibovitz's L-15 medium (L-15 medium) (Gibco, Eggenstein, Germany) and cultured for 30 min in L-15 medium containing CM-DiI (2 mM) and 2.5 S nerve growth factor (10 ng/ml, Wako). The cells were washed three times with L-15 medium and then incubated for 6 h in CM-DiI-free culture medium to remove any excess dye loaded in the DRG neurons. The absolute value of the number of DiI-labeled moving particles (/2 min) at the start of the experiments varied among the DRG neurons examined. This was probably due to certain differences in the culture conditions and/or developmental stages of the neurons. To characterize the particles stained with CM-DiI, double staining with CM-DiI and mitoTracker or erTracker was performed in DRG neurons. For double staining with CM-DiI and mitoTracker or erTracker, the cultured cells were incubated for 30 min in L-15 medium containing CM-DiI (2 μM) and mitoTracker (500 nM) or erTracker (1 μM), fixed, and analyzed under laser-scann ing microscopy (LSM510; Carl Zeiss, Jena, Germany). Cell viability was assessed via trypan blue exclusion cell counts (12) . The procedures involving the experimental animals complied with the animal care guidelines of the National Institutes of Health and the animal ethics committee of Yokohama City University.
Chick DRG culture and con-focal microscopy CM-DiI-labeled moving particles in the axons of cultured DRG neurons were observed using a laserscanning microscope with a water-immersed objective set at ×40 (C-Apochromat/1.2 W corr) equipped with an Axioplan 2 imaging microscope (Carl Zeiss). The images were typically 644 × 130 pixels, corresponding to an image size of 75 × 15.1 μm using a pixel size of 0.12 μm. The images were collected every 0.5 μs, at intervals of 0.25 μs, for 2 min.
Comparison between visual evaluation and computerassisted evaluation
We previously monitored and quantified axonal transport using video-enhanced DIC microscopy (6) . In this study, for quantification of the motility of the organelles, a line perpendicular to the long axis of the axon was drawn on the video monitor, and the number of moving organelles crossing the line was successively counted for each 2-min period. We first applied this method for the visual estimation of axonal transport by counting the number of CM-DiI-labeled particles moving along the axon. A line perpendicular to the long axis of the axon was drawn about 15 μm apart from the cell body, and the number of moving particles crossing the line was successively counted for every 2-min period throughout the experiments. By using our computer-assisted system, we evaluated the number of moving particles, and compared the evaluations obtained by visual observation and by the automated system on the same samples.
Data analyses
Data are expressed as means ± S.E.M. of n experiments. The results were analyzed by Student's t-test and the Mann-Whitney U-test.
Results
Visualization of CM-DiI-labeled moving particles along the axon
CM-DiI was used as a probe to visualize axonal transport. CM-DiI is highly fluorescent and photostable when incorporated into membranes and taken up by cytoplasmic vesicles by endocytosis (9) . To label the moving particles along the axon, the DRG neurons were cultured in media containing CM-DiI and incubated for 30 min. A de-staining process was required to visualize the moving particles in the DRG neurons; hence, the media was changed to L-15 medium and DRG neurons were further incubated for 6 h. Approximately three out of ten neurons per culture dish were stained with CM-DiI ( Fig. 1: A and  B) , in which the DiI-positive moving particles were clearly observed under confocal microscopy. In the stained neurons that were randomly selected, the CMDiI-labeled particles typically displayed a maximal diameter of 2.0 μm, a minimal diameter of 0.5 μm, and moved forward and backward along the axons. To characterize the CM-DiI-labeled particles, DRG neurons were double-stained with mitoTracker, a mitochondrial marker, and erTracker, a maker of the endoplasmic reticulum (ER). Some of the CM-DiI-positive particles were double-positive for erTracker (Fig. 1C) , suggesting that CM-DiI-positive particles contain ER. Some of the particles were CM-DiI and mitoTracker-double-positive, indicating that these CM-DiI-positive particles contain mitochondria (Fig. 1D) .
Establishment of a computer-assisted software system to monitor axonal transport
The following are the difficulties that appeared in analyzing the differential interference microscopic images:
1) The gray scale of the vesicle was not similar and the images had considerable random noise, which made vesicle detection difficult using simple image processing technologies.
2) The vesicles moved at differing velocities and in different directions.
3) Since the vesicles moved in close proximity in a narrow passageway, the particles may appear as a single particle on one image and then as several particles on the next image.
In order to overcome these difficulties, we established a computer-assisted software system to monitor axonal transport. First, we recorded the CM-DiI-labeled moving particles by using confocal microscopy. Next, the computer-assisted software system was used to analyze the images. There are two parts to the analysis -particle detection and particle tracking ( Fig. 2A) .
In the particle detection phase, the axonal region was first detected on an image after edge detection, which was first extracted from a differential interference microscopic image. An example of the resulting axonal region detection is shown in Fig. 2B . Subsequently, on the fluorescence microscopic images, noise reduction and particle shape enhancement were carried out using median filtering and convolution filtering, respectively. The resulting image revealed CM-DiI-labeled vesicles in the axonal regions. Since the vesicles had a wide range of intensities, general binarizing technologies do not always detect them stably. In order to solve this problem, a method to estimate the shape of particles using separability filtering (13) was applied for particle detection, which considered two designated regions as the central region R c and the surrounding region R s , and the ratio of the variances H = σ b 2 / σ i 2 of the inter-region to the intra-region was evaluated.
, where p r represents the intensities of the pixels r, n c , and n s , which are the number of pixels in the regions R c and R s ; and P c , P s , and P were the average intensities of pixels in R c , R s , and R c R s , respectively. Figure 2B shows the intensities in R c and R s . Since the variances σ c 2 and σ s In this method, particle tracking consists of local and global tracking. In the case of local tracking, the particles in each image frame corresponded to those in the successive frame, based on the weighted average of differences in the average intensity, the motion vector, and the detected size of the particles on the successive frames. To reduce the tracking errors that occurred on local tracking, we used a train schedule-like diagram, as shown in Fig.  2D . In the diagram, a line represents the time course of the movement of a given particle. We call it a particle movement diagram in this paper. Using the particle movement diagram, it was easy to determine whether a particle tracking route was stable or not. At the crossing points in the diagram, particles encounter or get in front of each other, which may increase the possibility of errors on the results of local tracking. On the other hand, where each particle moved alone on a line between crossing points, the likelihood of error would be considered to be low. In the case of global tracking, the tracking routes were first divided into stable route elements at the crossing points. Then, each stable route element combination was globally evaluated to find the set of optimum routes, so that the following evaluation function Ea would have the minimum value. This minimization was performed based on a genetic algorithm. 
An algorithm for axonal transport analysis An image processing algorithm of axonal transport analysis. The proposed algorithm for axonal transport analysis, which consists of two phases, particle detection and particle tracking (A). In panel B, a solid line shows the cross section of an image.
Where the size of region fits a vesicle, as in position (a), the variances σc 2 and σs 2 become low, and the difference between Pc and PS, high. The Hs have a high value at position (a) and a low value at (b). The detected particles are tracked by global evaluation using a particle movement diagram model after the determination of successive image frame correspondence. Examples of the results of particle detection (C) and of the particle movement diagram (D) are shown. In panel C, an input of the differential interference image (a), an image after detection of the axonal region detection (b), and a result of the particle detection on a fluorescence microscopic image frame (c) are shown. A magnified image of the boxed area in image c is shown in image d. In panel D, the lines represent the time course of the movement of each particle in the diagram, which is similar in appearance to a train schedule diagram. The circles in the figure show the crossing points in the diagram, where the particles encounter or get in front of each other. E) Parameters of a global reconstruction evaluation. Li, Ii, H, and Di are the time duration of the stable route element i, the time interval, the angle, and the distance between the element i and the successive routes, respectively. route element i and the successive route element i+1 in a given evaluation route; L i was the number of frames of the element i; and Lmax was the total number of frames, as shown in Fig. 2E . By minimizing E a , the elements that were smoothly connected without gaps and with a long path were selected for members in an evaluation route. The minimization in this study was implemented based on a genetic algorithm (14) , which was applied to these combinatorial optimization problems.
In this system, we evaluated the number and instantaneous velocity of particles moving along the axons of cultured DRG neurons. For the estimation of the number of moving particles, we first determined the coordinate origin in each frame. We then determined the x-axis of the virtual lines drawn every 1 μm on the axon and estimated the number of particles passing each of the virtual lines. We calculated the instantaneous velocity of each particle based on the number of frames required to pass through one interval (1 μm) of the virtual lines.
Application of the computer-assisted software to analyze axonal transport
Using this computer-assisted monitoring system, we characterized fluorescent anterograde and retrograde moving particles along the axons of DRG neurons. As mentioned above, the method for evaluating these particles was essentially the same as that employed in a DICmonitoring system: a line perpendicular to the long axis of the axon was drawn on the images approximately 15 μm apart from the cell body, and the number of organelles crossing the line was successively counted for 2 min. To compare the data obtained using conventional DIC microscopy and our present software program, we first performed visual evaluation of the number of CM-DiIlabeled particles passing the virtual line. The mean value of the number of both anterograde and retrograde moving particles was 12 -13 particles/min. In our previous study using video-enhanced DIC microscopy, 40 -50 particles/ min were found to pass through in both the anterograde and retrograde directions in mouse DRG neurons (6) . The difference in the mean value may be mainly due to differences in the resolving power and/or distinct populations of the moving organelles visualized by the two monitoring systems. Using our software system, the number of anterograde and retrograde CM-DiI-labeled moving particles was similar to the number obtained with visual evaluation (Table 1 ). This result supports the reliability and validity of this computer-assisted monitoring system.
Is axonal transport constant along the axon? We next estimated and compared the number of CM-DiI-labeled particles moving across successive lines drawn every 1 μm from the cell body and perpendicularly to the long axis of the axon (Fig. 3A) . We found that the number of anterograde and retrograde particles varied among the monitoring points along the axons (data not shown). This is consistent with the observation that the movement of organelles in axonal transport is saltatory, and individual organelles start and stop repeatedly (15) . To minimize data fluctuation, we estimated the summation of the data obtained from a total of 74 virtual lines drawn at intervals of 1 μm along the axon starting from the origin of the axon (Fig. 3B) . As a result, approximately 300 particles were estimated crossing the virtual lines drawn every 1 μm on the axon for a 2-min period of time using the computer-assisted software. The anterograde moving particle number was almost the same as the retrograde one (Fig. 3B) . The histogram of anterograde and retrograde axonal transport monitored with this system revealed a bimodal distribution pattern in anterograde axonal transport, with two peaks being observed at the velocity of 0.96 and 2.88 μm/s (Fig. 3C) . On the other hand, the histogram of retrograde axonal transport revealed a unimodal pattern, with one peak at the velocity of 0.72 μm/s (Fig. 3D) . These results are consistent with our previous data on anterograde and retrograde axonal transport monitored by DIC microscopy (6). The instantaneous velocity histogram of anterograde axonal transport displayed a similar bimodal distribution pattern, and retrograde transport exhibited a monophasic pattern (6).
CM-DiI-labeled vesicles are transported along microtubules
We further characterized CM-DiI-labeled particles moving along the axons by testing the effects of various pharmacological reagents. Intracellular membranous organelles are transported by ATP-dependent molecular motor proteins along microtubule and actin filaments (15) . To determine whether the CM-DiI-labeled vesicle was transported by this mechanism, we first investigated the effect of sodium azide, a known ATPase inhibitor. Sodium azide was reported to inhibit a membrane bound ATPase non-competitively with a Ki value of 39 μM (16). In our experiments, sodium azide at 15.4 μM markedly suppressed the percentage of control anterograde and retrograde axonal transport calculated from the value of the number of moving particles (/min) before the drugs in the cultured DRG neurons. Nocodazole is known to interfere with the polymerization of microtubules. Nocodazole at 30 μM also suppressed the anterograde and retrograde axonal transport. This is consistent with the previous report that nocodazole at μM ranges inhibits mitochondrial transport in axons in cultured hippocampal neurons (17) . In contrast, cytochalasin B at 10 μM produced no effect. Cytochalasin B at 5 μM inhibits axonal transport of neurofilaments, which is dependent on actin and myosin (18) . We examined the time course of changes in axonal transport before and after the application of these drugs. For both anterograde and retrograde axonal transport, the plateau effects of sodium azide and nocodazole were seen 4 and 30 min after the application, respectively. Cytochalasin B essentially produced no effect (data not shown). For anterograde transport, the value estimated for a 2-min period of time before and 4 or 30 min after the application of sodium azide or nocodazole was 332 ± 65 and 59 ± 17 (n = 5) or 243 ± 24 and 88 ± 26 (n = 5), respectively. For retrograde transport, the value estimated for a 2 min-period of time before and 4 or 30 min after the application of sodium azide or nocodazole was 291 ± 62 and 104 ± 26 (n = 5) or 189 ± 28 and 85 ± 23 (n = 5), respectively. Taken together, these results suggest that movement of CM-DiI-labeled particles in the DRG axons represented ATP-dependent and microtubule-based active transport.
Assessment of the effects of drugs on axonal transport of CM-DiI-labeled particles
Various kinds of therapeutic agents have neurological side effects, and some have been associated with the impairment of axonal transport (18) . However, due to the lack of a valid method for the quantitative evaluation of axonal transport, systemic drug screening based on the effects on axonal transport has not been reported. We investigated the effects of various pharmacological reagents on axonal transport and checked whether our automated analysis system was applicable in this regard: this comprised an important proof-of-principle required for the further development of drug screening. We first tested the effects of lidocaine on axonal transport in DRG neurons. Lidocaine is widely used as a local anesthesia and has been reported to exert an inhibitory effect on axonal transport (19) . Lidocaine (10 mM) decreased the number and the velocity of the CM-DiI-labeled vesicles (Fig. 4) . The lower concentrations of lidocaine (0.1 and 1 mM) produced no effect (data not shown). Interestingly, lidocaine preferentially suppressed the anterograde and retrograde moving particles with a velocity of less than 2.16 μm/s (Fig. 4: C and D) .
The effects of anti-neoplastic drugs on axonal transport
Many anti-cancer drugs have neuropathic side effects (20 -22) . However, the mechanisms for these untoward effects are largely unknown. We investigated the effects of anti-cancer drugs on axonal transport using our system. We treated DRG neurons with paclitaxel, vincristine, cisplatin, oxaliplatin, methotrexate, and 5-fluorouracil.
Paclitaxel stimulates and vincristine inhibits the polymerization of β-tubulin to α-tubulin, resulting in the appearance of microtubule bundles and some aberrant structures in the mitotic phase of the cell cycle (23) . Cisplatin and oxaliplatin react with DNA, forming both intrastrand and interstrand cross-links. Cisplatin also inhibits the polymerization of microtubules. Methotrexate, an inhibitor of enzyme dihydrofolate reductase, and 5-fluorouracil, an inhibitor of thymidine monophosphate, inhibit DNA synthesis.
Using the system we devised, we found that paclitaxel, vincristine, cisplatin, and oxaliplatin disrupted both anterograde and retrograde axonal transport and decreased the number of CM-DiI-labeled moving particles (Fig. 5) . We confirmed concentration-dependent inhibition by paclitaxel (1, 10, and 100 nM), vincristine (10, 50, and 100 pM), and cisplatin (0.1, 1, and 10 μM) of both anterograde and retrograde axonal transport (Fig. 6) . The IC 50 value for anterograde or retrograde axonal transport of paclitaxel, vincristine, and cisplatin were 4.1 or 5.5 nM, 100 or 130 pM, and 3.0 or 5.5 μM, respectively. These values are comparable to the effective concentrations that inhibit the growth of tumor cells (20 -22) . It is still possible that inhibition of paclitaxel, cisplatin, and oxaliplatin of axonal transport is due to a secondary effect of cytotoxicity of these agents in DRG neurons. By trypan blue staining, we estimated cell viability at the end of the DiI-labeled experiments with or without treatment of these drugs. The cell viability was 60%, which showed no difference among the non-treated and cispla- tin at 0.1, 1, or 10 μM-treated groups (data not shown).
In addition, 5-FU and methotrexate at the cytotoxic concentration of 100 μM produced no effects on anterograde and/or retrograde axonal transport in DRG neurons. Thus, it is unlikely that the effects of these anti-neoplastic reagents on axonal transport were due to secondary cytotoxic effects of these agents.
Oxaliplatin showed a tendency to inhibit the fast component of anterograde and retrograde axonal transport with a velocity faster than 2 μm/s (Fig. 5) . On the other hand, paclitaxel inhibited moving particles with a velocity slower than 3 μm/s (Fig. 5) . 5-Fluorouracil and methotrexate did not produce significant effects on axonal transport, although these agents did increase the fast and the slow components of anterograde and retrograde axonal transport, respectively (Fig. 7) .
Discussion
Although axonal transport is fundamental for neuronal function and survival, there have been no reported pharmacological analyses of substances that may modulate axonal transport. Membranous organelles are transported by fast axonal transport, whereas cytosolic and cytoskeletal proteins are transported by slow axonal transport (14) . In the present study, we developed a computer-assisted software system for a simple and quantitative monitoring of fast axonal transport. Using this system, we found that antineoplastic agents differentially affected anterograde and retrograde axonal transport. This software is a useful tool for studying axonal transport regulatory mechanisms.
The algorithm in a computer-assisted system consists of two phases, particle detection and particle tracking. Particles were detected by estimating the shape of particles with a separability filter in the axonal region. Next, successive images of the corresponding particles were tracked by means of a global evaluation using a particle movement diagram model. This configuration enabled precise and stable detection of vesicle movement. To validate this new method, we comparatively estimated anterograde and retrograde axonal transport by visual evaluation as well as the newly developed software. As shown in Table 1 , the number of anterograde and retrograde moving particles estimated by the software was essentially consistent with that estimated by visual evaluation. Furthermore, several compounds that have been previously demonstrated to inhibit axonal transport, such as sodium azide or nocodazole, were shown by the software to inhibit axonal transport. This indicates that anterograde and retrograde flow of CM-DiI-labeled particles is ATP-and microtubule-dependent, representing the fundamental features of fast axonal transport (24) . The validity of this method is also supported by the speed distribution of the particle movement. The speed of the anterograde moving particles exhibited a bimodal pattern, while that of the retrograde moving particles was unimodal. This observation is consistent with the characteristics of axonal transport described previously (6, 25) . In fact anterograde axonal transport is mediated by multiple motor proteins, including both kinesins and dynein, while retrograde transport is mainly mediated by cytoplasmic dynein (15) . Thus, the bimodal pattern of anterograde transport may reflect transport by multiple motor proteins, and the unimodal pattern of retrograde transport may reflect transport by cytoplasmic dynein alone.
Using our software, we analyzed the effects of lidocaine and several anti-cancer drugs on axonal transport. Lidocaine, a local anesthetic, also reportedly impairs axonal transport (19, 26) . We found that lidocaine decreased the number of anterograde and retrograde axonal transport of CM-DiI-labeled particles. The minimum dose of lidocaine that affected axonal transport was 10 mM. This effective concentration is higher than that observed with DIC microscopy, in which lidocaine inhibits axonal transport with an IC 50 of 10 μM (19) . Although the reasons for this discrepancy are unknown, it may be due to differences in the moving particles or membranous organelles which were visualized by the two different experimental systems. In fact, CM-DiI-labeled cellular components have not been fully characterized yet (9) . We studied the subcellular distribution of CM-DiI by using the two markers, erTracker and mitoTracker, for ER and mitochondria, respectively. Some of the CMDiI-labeled particles were double-stained with erTracker and mitoTracker ( Fig. 1: C and D) . The fractions of these double-positive particles were small, indicating that the majority of the CM-DiI-labeled particles do not contain ER and mitochondria. In a previous report, the subcellular distribution of CM-DiI was studied in cultured cortical neurons. The signal of CM-DiI in the Golgi was reportedly very faint, while CM-DiI was initially seen in the cell membrane and subsequently observed (30 min) in the endosomes and lysosomes labeled with Lyso Tracker Bodipy (9). We confirmed this by introduction of the lysosomal marker protein EGFP-tagged lysosomalassociated membrane protein 1 (27) into DRG neurons, most of which were double-stained with DiI (data not shown). These findings suggest that the majority of the moving particles labeled with CM-DiI are composed of endosomes and lysosomes in DRG neurons.
Chemotherapy with anti-cancer drugs is often toxic and yet requires prolonged administration, thus eventually resulting in adverse side effects such as peripheral neuropathy and neuropathic pain. Impairment of axonal transport has been implicated in chemotherapeutic druginduced peripheral neuropathy, but the causal relationship and the mechanism of axonal transport in drug-associated neurological toxicity remain largely unknown (28) . In the present study, several anti-cancer drugs, including paclitaxel, vincristine, cisplatin, and oxaliplatin, suppressed axonal transport at the effective concentrations for inhibiting tumor cell growth (20 -22) . This suppression of axonal transport might be commonly shared by these anti-neoplastic agents that cause neurological toxicity (28) .
Interestingly, these drugs exerted differential effects on anterograde and retrograde axonal transport. For example, vinscristine and oxaliplatin preferentially inhibited the fast component of anterograde and retrograde axonal transport. On the other hand, lidocaine inhibited the slower component of both anterograde and retrograde transport. Axonal transport is carried out by multiple motor proteins, and each motor has a characteristic velocity (15) . This suggests that these agents have distinct sites of action that are involved in their differential effects on axonal transport.
In conclusion, we have established a system allowing prompt and accurate analysis of axonal transport that can visualize moving particles. This system, applied together with other probes and recent imaging techniques, would afford a strategy for developing novel therapeutic agents to restore affected axonal transport in various kinds of neuronal cells originating from central and peripheral nervous tissue or disease-related pluripotent stem cells (29) .
